UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.718

Sortiert nach

New insight of chemical constituents in Persea americana fruit against obesity via integrated pharmacology

Clinical and translational science, 2024-03, Vol.17 (3), p.e13778-n/a

2024

Volltextzugriff (PDF)

A scheme to underpin key mediator(s) in Salinosporamide(s) against pan-tumor via systems biology concept

Journal of translational medicine, 2024-05, Vol.22 (1), p.492-492, Article 492

2024

Volltextzugriff (PDF)

A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology

Journal of translational medicine, 2024-03, Vol.22 (1), p.262-7, Article 262

2024

Volltextzugriff (PDF)

Microbiota-based treatments in alcoholic liver disease

World journal of gastroenterology : WJG, 2016-08, Vol.22 (29), p.6673-6682

2016

Volltextzugriff (PDF)

The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology

Journal of translational medicine, 2024-03, Vol.22 (1), p.279-6, Article 279

2024

Volltextzugriff (PDF)

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease

International journal of molecular sciences, 2021-08, Vol.22 (15), p.8309

2021

Volltextzugriff (PDF)

The synchronized feature of Saururus chinensis and gut microbiota against T2DM, NAFLD, obesity and hypertension via integrated pharmacology

Artificial cells, nanomedicine, and biotechnology, 2024-12, Vol.52 (1), p.278-290

2024

Volltextzugriff (PDF)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

Journal of translational medicine, 2023-04, Vol.21 (1), p.263-263, Article 263

2023

Volltextzugriff (PDF)

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics

Clinical and translational medicine, 2023-09, Vol.13 (9), p.e1392-e1392

2023

Volltextzugriff (PDF)

A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis

Artificial cells, nanomedicine, and biotechnology, 2024-12, Vol.52 (1), p.250-260

2024

Volltextzugriff (PDF)

Rap1 regulates hepatic stellate cell migration through the modulation of RhoA activity in response to TGF‑β1

International journal of molecular medicine, 2019-08, Vol.44 (2), p.491-502

2019

Volltextzugriff (PDF)

The Role of the Gut Microbiome in Liver Cirrhosis Treatment

International journal of molecular sciences, 2020-12, Vol.22 (1), p.199

2020

Volltextzugriff (PDF)

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease

Current issues in molecular biology, 2022-07, Vol.44 (7), p.3253-3266

2022

Volltextzugriff (PDF)

The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis

Artificial cells, nanomedicine, and biotechnology, 2023-12, Vol.51 (1), p.217-232

2023

Volltextzugriff (PDF)

New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study

Artificial cells, nanomedicine, and biotechnology, 2023-12, Vol.51 (1), p.1-12

2023

Volltextzugriff (PDF)

Outcome of Intermittent Thoracentesis versus Pigtail Catheter Drainage for Hepatic Hydrothorax

Journal of clinical medicine, 2022-12, Vol.11 (23), p.7221

2022

Volltextzugriff (PDF)

Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease

Gut and Liver, 2023, 17(2), , pp.299-307

2023

Volltextzugriff (PDF)

Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study

Cells (Basel, Switzerland), 2022-09, Vol.11 (18), p.2903

2022

Volltextzugriff (PDF)

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

Expert review of gastroenterology & hepatology, 2019-03, Vol.13 (3), p.193-204

2019

Volltextzugriff (PDF)

Microbiome and Metabolomics in Liver Cancer: Scientific Technology

International journal of molecular sciences, 2022-12, Vol.24 (1), p.537

2022

Volltextzugriff (PDF)

Hepatic venous pressure gradient: clinical use in chronic liver disease

Clinical and molecular hepatology, 2014-03, Vol.20 (1), p.6-14

Suk, Ki Tae

2014

Volltextzugriff (PDF)

Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction

Gastrointestinal endoscopy, 2006-10, Vol.64 (4), p.522-529

2006

Volltextzugriff (PDF)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role

Biomedicines, 2022-02, Vol.10 (3), p.550

2022

Volltextzugriff (PDF)

Platelet-to-White Blood Cell Ratio: A Feasible Biomarker for Pyogenic Liver Abscess

Diagnostics (Basel), 2022-10, Vol.12 (10), p.2556

2022

Volltextzugriff (PDF)

Microbiome and metabolomics in alcoholic liver disease

Clinical and Molecular Hepatology, 2022, 28(3), , pp.580-582

2022

Volltextzugriff (PDF)

1 – 25 von 1.718

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.489)
Mit Volltextzugriff
(1.619)

Publikationsform

Sprache

Englisch
(1.404)
Koreanisch
(309)
Japanisch
(158)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.006)
Life Sciences & Biomedicine
(771)
Humans
(497)
Female
(352)
Male
(345)
Middle Aged
(288)
Adult
(224)
Aged
(217)
Physical Sciences
(168)
Oncology
(152)
Technology
(149)
Gastroenterology & Hepatology
(140)
Animals
(129)
Biological And Medical Sciences
(119)
Treatment Outcome
(106)
Chemistry
(104)
Risk Factors
(100)
Medical Sciences
(98)
Original
(95)
Science & Technology - Other Topics
(84)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(24)

Menü

Weitere Dienste

Einstellungen

New insight of chemical constituents in Persea americana fruit against obesity via integrated pharmacology

A scheme to underpin key mediator(s) in Salinosporamide(s) against pan-tumor via systems biology concept

A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology

Microbiota-based treatments in alcoholic liver disease

The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease

The synchronized feature of Saururus chinensis and gut microbiota against T2DM, NAFLD, obesity and hypertension via integrated pharmacology

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics

A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis

Rap1 regulates hepatic stellate cell migration through the modulation of RhoA activity in response to TGF‑β1

The Role of the Gut Microbiome in Liver Cirrhosis Treatment

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease

The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis

New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study

Outcome of Intermittent Thoracentesis versus Pigtail Catheter Drainage for Hepatic Hydrothorax

Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease

Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

Microbiome and Metabolomics in Liver Cancer: Scientific Technology

Hepatic venous pressure gradient: clinical use in chronic liver disease

Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role

Platelet-to-White Blood Cell Ratio: A Feasible Biomarker for Pyogenic Liver Abscess

Microbiome and metabolomics in alcoholic liver disease

Suchergebnisse filtern